No Data
No Data
Autobio Diagnostics (603658.SH): Has repurchased 1.00% of its shares.
On August 1st, Gelunhui reported that as of July 31, 2024, Autobio Diagnostics (603658.SH) has repurchased a total of 5,810,170 shares through centralized bidding transactions, accounting for 1.00% of the company's total share capital, an increase of 0.2968% compared to the previously disclosed number. The highest transaction price was 59.99 yuan/share, the lowest transaction price was 40.48 yuan/share, and the total amount paid was 289,849,009.68 yuan (excluding transaction fees).
Autobio Diagnostics Gets Registration Certificates for 14 Devices
Autobio Diagnostics (603658.SH) has obtained 14 registrations for medical instruments.
Autobio Diagnostics (603658.SH) announced that the company has recently received a pharmaceutical license issued by the Henan Provincial Administration of Drug Supervision.
Autobio diagnostics (603658.SH): has repurchased 0.7032% of the shares.
On July 1, Gelunhui reported that Autobio Diagnostics (603658.SH) has announced that as of June 30, 2024, the company has cumulatively repurchased 4,122,770 shares through centralized bidding trading, accounting for 0.7032% of the total share capital of the company. The highest transaction price was 59.99 yuan/share and the lowest was 47.61 yuan/share. The total amount paid was 216,014,211.60 yuan (excluding transaction fees).
Little Excitement Around Autobio Diagnostics Co., Ltd.'s (SHSE:603658) Earnings
Autobio Diagnostics (603658.SH) has repurchased 0.4005% of its shares.
On June 3, Gelon Hui reported that Autobio Diagnostics (603658.SH) has announced that, as of May 31, 2024, the company has accumulated 2,347,970 shares through centralized bidding buy-back, accounting for 0.4005% of the total share capital of the company. The highest transaction price was 59.99 yuan/share, the lowest price was 51.54 yuan/share, and the total amount paid was 129,808,722.60 yuan (excluding transaction fees).
No Data